The Latest Articles from Streetwise Reports


Firm Sees Boost in Sales of Health Chewable for Dogs

Research Report
  ()
Recent orders from Avivagen Inc. are helping the developer of this product build a recurring revenue stream, noted a Noble Capital Markets report.

Analyst Update

Healthcare Co. Enters US Alcohol Addiction Treatment Market

  ()
One analyst says this healthcare co. has the opportunity to generate attractive CAPEX-light, high margin SaaS-like recurring revenues, which investors are currently getting for free, after the biotech firm entered the US market for alcohol addiction treatment through off-label licensing deals with a network of treatment clinics.

Rare Earths Co. Raises AU$45 Million

Research Report
  ()
These funds, including US$30M from a strategic investor, should see Vital Metals Ltd. through extraction facility commissioning, now underway, noted an MST Access report.

Co. Provides Ground-Floor Opportunity in Precision Oncology

Research Report
  ()
Nuvectis Pharma Inc recently announced quarterly financial results and is continuing to advance its precision oncology programs. H.C. Wainwright & Co. LLC advised in an earnings update that the firm offers significant upside potential as it is rapidly advancing its drug candidates through clinical development and is looking for ways to expand to markets outside of the U.S. H.C. Wainwright stated that it is reiterating its Buy rating and $21 price target for Nuvectis Pharma.

HSCT/Gene Therapy Co. Sees Many Positive Catalysts in Q422

Research Report
  ()
Hematopoietic stem cell transplantation (HSCT) and gene therapy firm Magenta Therapeutics Inc. recently announced updates related to two of its leading clinical programs. BTIG LLC advised in a research update that it expects Magenta to release updated clinical data from its MGTA-117 and MGTA-145 programs in Q4/22, which will serve as key catalysts for the company. BTIG stated it is reiterating its "Buy" rating and $6/share price target on Magenta Therapeutics.

Expert Expects Life Science Co. To Do Exceptionally Well

  ()
Avivagen is an early-stage life sciences company with a patented product for immune support that causes dramatic and profitable improvements in livestock. They have been increasing their sales and market penetration at a dramatic rate, and I believe them to be at an inflection point. Research coverage is expecting a 7x return.

Mexican Silver Explorer Going For Gold in Chihuahua

  ()
A junior silver explorer operating in Mexico’s Parral region believes its drill campaign revealed more than just promising gold-silver grades – he thinks his company is onto something much bigger. And that perhaps the entire camp is open to re-evaluation.
Tags:  GoldSilver

Residual Gold Present in Historical Leach Pads at Utah Asset

Research Report
  ()
This means the pads could be leached again, and cyanide solubility test results indicate the process could be done economically, noted a PI Financial report.
Tags:  Gold

Infrastructure Co. Creates Field of Dreams for Energy Producers

  ()
Energy services and specialty equipment rental supplier Enterprise Group Inc. reported earnings for Q2/22, which included a 64% YoY increase in revenue along with substantial growth in gross margins and adjusted EBITDA. The company is now heading into the busy peak winter drilling season with a new arsenal of natural gas fueled generators that enable oil & gas drillers and natural resource firms to greatly reduce on-site CO2 emissions, meet and exceed mandated ESG requirements, and in the process, save thousands of dollars per day by eliminating the need for diesel-powered generators.

'Compelling' PFS Expected for Rare Earth Project

Research Report
  ()
There is significant potential to expand Defense Metals Corp.'s current resource and extend the mine life, noted a Noble Capital Markets report.

Energy Co. Helping Explorers Switch From Diesel Fuel to Natural Gas

Contributed Opinion
  ()
With Enterprise Group Inc.'s stocks steadily improving, expert Clive Maund reviews the latest updates with the company, including news with its wholly owned subsidiary Evolution Power Projects Inc.

Junior Explorer Hits 'Bonanza Grade' Silver in Golden Triangle

  ()
Dolly Varden Silver Corp. releases results from the first hole in its 30,000-meter drilling campaign at its sprawling Kitsault Valley project in British Columbia.
Tags:  Silver

Lion One Gets 10-year Extension at Fiji Gold Project

  ()
One analyst believes a 10-year extension of a mining lease at a high-grade gold project in Fiji could put a junior gold play in the crosshairs of companies looking to add ounces.
Tags:  Gold

Copper Update and a Promising Copper Stock

Contributed Opinion
  ()
Expert Clive Maund reviews the latest updates in copper stocks and how he thinks this turnaround will effect copper company Infinitum Copper.

Mining Lease Extension Helps Derisk Gold Project in Fiji

Research Report
  ()
The significant growth potential of the project also enhances its profile as a takeout target, noted a ROTH Capital Partners report.
Tags:  Gold

Feedstock Additive Co. Gets Massive Order for Brazil Market

  ()
The widespread use of antibiotics in animal feeds, as well as over-prescription by physicians for therapeutic treatment of human infections, is leading to a growing resistance to antibiotics that is killing close to 1 million people each year. One company believes it has developed at least part of the solution through a beta carotene food additive that boosts immunity and contributes to better overall health.

Co.'s 'Monster' Earnings Surpass Analyst's Forecast

Research Report
  ()
Big earnings results posted by Data Communications Management Corp. have led an analyst to raise his target and estimates for the company.
Tags:  Technology

Expert Says, 'Royalties Have Advantage During Price Inflation'

Contributed Opinion
  ()
More resource companies released quarterly earnings, but since in all cases production and other items had been pre-released, there were few surprises for expert Adrian Day.
Tags:  Gold

Expert Rates Digital Printing Co. An Immediate Speculative Buy

Contributed Opinion
  ()
Expert Clive Maund reviews the most recent updates from digital printing company Data Communications Management Corp. to tell you whether or not he believes it is a Buy.
Tags:  Technology

Testing Confirms Drug Candidate Differs From Peers

Research Report
  ()
Biotech ProMIS Neurosciences Inc.'s monoclonal antibody in development for Alzheimer's disease boasts a "unique" binding profile that could be "important to its clinical success," noted a Leede Jones Gable report.

Demand for Co.’s Antibiotic Free Animal Feed Is Raising

Contributed Opinion
  ()
With consumers moving away from artificial meat products and other preservatives, Avivagen Inc.'s antibiotic free animal feed seems to be just what they're looking for. With orders coming in and demand raising, expert Clive Maund shares his view on the potential of this life science company.

Why These Two Analysts Are Following Emerita

  ()
The latest data from Emerita Resources Corp. may support growth of the company's overall project resource, noted a Clarus Securities report.

Canadian Marketing Co. Pivots From Print to Digital

  ()
One of Canada’s largest printing and marketing services company is growing its coffers by expanding its digital footprint.
Tags:  Technology

Showing Results: 1 to 25 of 505 Next

Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe

More Experts